Andrew J. Schwab, 10% Owner at Entrada Therapeutics, Inc. (TRDA), bought 568,616 shares at $20.00 ($5.0M) on 2021-11-02, disclosed to the SEC on 2021-11-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 318,616 | $0 | 0.0% |
| 2 | $20.00 | 250,000 | $5.0M | 100.0% |
| Total | $8.79 avg | 568,616 | $5.0M | 100% |
| Filing → |
| CAMP | SELL | 2026-08-31 | $1.6M | — | Filing → |
| CAMP | SELL | 2026-08-26 | $45 | — | Filing → |
| CAMP | SELL | 2026-08-21 | $880K | — | Filing → |